• Why Attend?
  • Speakers
  • Contact Us

Why Attend?

From radiopharmaceuticals to cell and gene therapies, the rise of speciality therapeutics is driving a robust pipeline of innovative therapies, with expanding commercial opportunities. Yet from logistics and order-to-cash to market access and global expansion, launch teams must navigate a growing number of operational and regulatory requirements.

Explore how Cencora brings together logistics, distribution, order-to-cash management, title model solutions, and market-entry consulting to create an integrated launch approach that helps launch teams to overcome these complexities.

Discover how an integrated model enables companies to launch efficiently, reduce operational burden, and maintain ownership of their commercialization strategy as they expand globally.

Learning Objectives of this webinar:

  • Understand the size and growth drivers of the speciality pharmaceuticals market through GlobalData’s pipeline data, clinical trials intelligence, and analyst commentary
  • ​​Learn how integrated logistics can reduce complexity and improve execution across global markets​
  • ​​Discover how end-to-end order-to-cash services reduces the administrative burden placed on internal launch teams and alleviates the pressure to scale up international teams​
  • ​​Understand how title model solutions provide manufacturers with greater flexibility and support market entry, improve cash-flow efficiency, and preserve ownership​
  • ​​Identify the key operational and regulatory challenges that launch teams face when scaling globally.

Speakers

Select a speaker to learn more

Back
​​Gert Jan Van Der Hulst​
​​Vice President, Integrated Solutions and Commercialization​, Cencora

GertJan (GJ) brings 25+ years commercial experience across clinical development and commercialisation. He has broad experience across clinical development and market access with leading CROs like ICON, PAREXEL and PPD. In his current role VP Integrated Solutions & Commercialisation he leverages Cencora’s foundations to bring integrated outsourced commercial services to emerging biotechs in Europe and/or the US.

Next speaker
Back
Krystal Haynes
​​Senior Director, International 3PL Business Development, Cencora

​​Krystal Haynes serves as the Senior Director of International 3PL Business Development for ICS – part of the Cencora family of companies. In her role, Krystal is responsible for the strategic and operational oversight of the ICS business development team, supporting manufacturers for their commercial launch, including innovative cell and gene therapies.​

Next speaker
Back
David de Wit
Director, Regional Specialty Solutions, Cencora

David de Wit has 20 years of experience across general management, operations, and sales, and brings deep expertise and a practical, people-focused leadership style. David’s background spans logistics, express, air and road freight, warehousing, value-added logistics services, contract logistics, time-critical services, and e-commerce. He currently serves as Regional Director, Specialty Solutions at Cencora 3PL, and holds an MBA from Radboud University.

Next speaker
Back
Fiona Chisholm
Associate Director for Infectious Diseases, GlobalData

Fiona Chisholm, BSc, MSc, is the Associate Director for Infectious Diseases at GlobalData. She is primarily responsible for managing the development and delivery of market research projects within GlobalData’s Infectious Disease portfolio. Fiona has over 10 years’ experience within the healthcare industry. Her extensive R&A experience includes authoring, quality control and project management of syndicated and custom research projects across a range of therapy areas. Fiona previously worked at GBI Research and Catalent Pharma Solutions prior to joining GlobalData.

Next speaker

Enquiry